Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-39.42	-170.47	-122.27
Graham Fair Price	-35.72	0.21	0.32
PEG	835.00	0.74	0.08
Price/Book	-19.17	28.13	34.81
Price/Cash Flow	23.45	-349.25	-456.26
Prices/Earnings	-58.56	-40.09	-25.29
Price/Sales	5.07	34.10	32.46
Price/FCF	23.45	-349.25	-456.26
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1504.41	0.07	< 0.005
Operating Margin	28.40	-0.22	-0.31
ROA	53.40	-0.04	-0.08
ROE	-0.34	-0.18	49.02
ROIC	-0.22	-0.13	43.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.19	4.35	-95.53
Dividends QOQ	0.31	-0.81	164.22
EBIT QOQ	-0.47	0.50	7.30
EPS QOQ	-3.19	0.54	-83.04
FCF QOQ	0.43	0.05	-88.65
Revenue QOQ	-0.14	-0.31	-118.49
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	10.36	19.37	87.08
Days Sales Outstanding (DSO)	196.08	279.47	42.53
Inventory Turnover	8.69	4.65	-46.55
Debt/Capitalization	0.34	0.31	-7.21
Quick Ratio	1.08	1.02	-5.02
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.12	0.10	-9.97
Cash	0.08	0.08	-10.09
Capex	< 0.005	< 0.005	-35.83
Free Cash Flow	< 0.005	< 0.005	4.93
Revenue	0.12	0.09	-30.74
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.16	1.13	-2.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.77	1.65	114.79
Naive Interpretation	Member

06 - Financial Health · Bad

Rating